Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.

Fernandéz JR, Rouzard K, Voronkov M, Feng X, Stock JB, Stock M, Gordon JS, Shroot B, Christensen MS, Pérez E.

J Cosmet Dermatol. 2012 Dec;11(4):272-8. doi: 10.1111/jocd.12002.

PMID:
23174050
2.

Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials.

Slade HB, Shroot B, Feldman SR, Cargill DI, Stanfield J.

Photodermatol Photoimmunol Photomed. 2009 Jun;25(3):146-52. doi: 10.1111/j.1600-0781.2009.00433.x.

PMID:
19438994
3.

Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.

Pavez Loriè E, Cools M, Borgers M, Wouters L, Shroot B, Hagforsen E, Törmä H, Vahlquist A.

Br J Dermatol. 2009 Jan;160(1):26-36. doi: 10.1111/j.1365-2133.2008.08895.x. Epub 2008 Oct 21.

PMID:
19016711
4.

Claudin 2 mRNA and protein are present in human keratinocytes and may be regulated by all-trans-retinoic acid.

Telgenhoff D, Ramsay S, Hilz S, Slusarewicz P, Shroot B.

Skin Pharmacol Physiol. 2008;21(4):211-7. doi: 10.1159/000135637. Epub 2008 May 29.

PMID:
18509255
5.

Influence of papain urea copper chlorophyllin on wound matrix remodeling.

Telgenhoff D, Lam K, Ramsay S, Vasquez V, Villareal K, Slusarewicz P, Attar P, Shroot B.

Wound Repair Regen. 2007 Sep-Oct;15(5):727-35.

PMID:
17971019
6.

Great expectations--SID and industry relationship: a 20-year perspective.

Shroot B.

J Invest Dermatol. 2007 Jul;127(7):1561-2. No abstract available.

7.

Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.

Bikowski J, Shroot B.

J Drugs Dermatol. 2006 Nov-Dec;5(10):942-6. Review.

PMID:
17373142
8.

The position not the presence of the halogen in corticosteroids influences potency and side effects.

Bikowski J, Pillai R, Shroot B.

J Drugs Dermatol. 2006 Feb;5(2):125-30. Review.

PMID:
16485880
9.

Further evidence of multifunctionality in the keratinocyte: the endothelial protein C receptor.

Telgenhoff D, Shroot B.

J Invest Dermatol. 2005 Dec;125(6):xviii-xix. No abstract available.

10.

Cellular senescence mechanisms in chronic wound healing.

Telgenhoff D, Shroot B.

Cell Death Differ. 2005 Jul;12(7):695-8. No abstract available.

11.

Further light is shed on topical therapy.

Shroot B.

J Invest Dermatol. 2003 Sep;121(3):xiii-xiv. Review. No abstract available.

12.

Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition.

Dawson MI, Park JH, Chen G, Chao W, Dousman L, Waleh N, Hobbs PD, Jong L, Toll L, Zhang X, Gu J, Agadir A, Merchant JL, Bai L, Verma AK, Thacher SM, Chandraratna RA, Shroot B, Hill DL.

Int J Cancer. 2001 Jan 1;91(1):8-21.

13.
14.

Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis.

Fontana JA, Dawson MI, Leid M, Rishi AK, Zhang Y, Hsu CA, Lu JS, Peterson VJ, Jong L, Hobbs P, Chao WR, Shroot B, Reichert U.

Int J Cancer. 2000 May 15;86(4):474-9.

15.

Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.

Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R.

Clin Cancer Res. 2000 Apr;6(4):1563-73.

16.

S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid.

Zhang Y, Rishi AK, Dawson MI, Tschang R, Farhana L, Boyanapalli M, Reichert U, Shroot B, Van Buren EC, Fontana JA.

Cancer Res. 2000 Apr 1;60(7):2025-32.

17.

Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.

Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B, Nau H.

Arch Toxicol. 2000 Jan;73(10-11):547-56.

PMID:
10663386
18.

Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437.

Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS, Dawson MI, Reichert U, Shroot B, Fornace AJ Jr, Brewer G, Fontana JA.

Nucleic Acids Res. 1999 Aug 1;27(15):3111-9.

19.

Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells.

Sun SY, Yue P, Shroot B, Hong WK, Lotan R.

Oncogene. 1999 Jul 1;18(26):3894-901.

20.

Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.

Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R.

Cancer Res. 1999 Jun 15;59(12):2829-33.

21.

Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.

Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R.

Oncogene. 1999 Apr 8;18(14):2357-65.

22.

Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3.

Liang JY, Fontana JA, Rao JN, Ordonez JV, Dawson MI, Shroot B, Wilber JF, Feng P.

Prostate. 1999 Feb 15;38(3):228-36.

PMID:
10068347
23.

Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid.

Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson M, Poirer G, Fontana JA.

Exp Cell Res. 1999 Feb 25;247(1):233-40.

PMID:
10047465
24.

Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.

Sun SY, Kurie JM, Yue P, Dawson MI, Shroot B, Chandraratna RA, Hong WK, Lotan R.

Clin Cancer Res. 1999 Feb;5(2):431-7.

25.

A selective retinoid with high activity against an androgen-resistant prostate cancer cell type.

Lu XP, Fanjul A, Picard N, Shroot B, Pfahl M.

Int J Cancer. 1999 Jan 18;80(2):272-8.

26.

Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.

Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.

Oncol Res. 1998;10(6):313-24.

PMID:
9848102
27.

Pharmacodynamics and pharmacokinetics of topical adapalene.

Shroot B.

J Am Acad Dermatol. 1998 Aug;39(2 Pt 3):S17-24. Review. No abstract available.

PMID:
9703119
28.

Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines.

Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D, Zhang XK.

Mol Cell Biol. 1998 Aug;18(8):4719-31.

29.

A new concept of drug delivery for acne.

Shroot B, Michel S, Allec J, Chatelus A, Wagner N.

Dermatology. 1998;196(1):165-70.

PMID:
9557255
30.

Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.

Sun SY, Yue P, Shroot B, Hong WK, Lotan R.

J Cell Physiol. 1997 Nov;173(2):279-84.

PMID:
9365537
31.

Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.

Carpentier A, Balitrand N, Rochette-Egly C, Shroot B, Degos L, Chomienne C.

Oncogene. 1997 Oct 9;15(15):1805-13.

32.

Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.

Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R.

Cancer Res. 1997 Nov 1;57(21):4931-9.

33.
34.

Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.

Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC, Fontana JA.

Blood. 1997 Jun 15;89(12):4470-9.

PMID:
9192771
35.

Pharmacology and chemistry of adapalene.

Shroot B, Michel S.

J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S96-103. Review.

PMID:
9204085
36.
37.

Bcl-X(L) expression and its downregulation by a novel retinoid in breast carcinoma cells.

Hsu CK, Rishi AK, Li XS, Dawson MI, Reichert U, Shroot B, Fontana JA.

Exp Cell Res. 1997 Apr 10;232(1):17-24.

PMID:
9141616
38.

Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphtalene carboxylic acid (CD437).

Oridate N, Higuchi M, Suzuki S, Shroot B, Hong WK, Lotan R.

Int J Cancer. 1997 Feb 7;70(4):484-7. No abstract available.

39.

Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells.

Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B, Reichert U, Ordonez J, Fontana JA.

Cancer Res. 1996 Nov 1;56(21):5055-62.

41.

Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.

Charpentier B, Bernardon JM, Eustache J, Millois C, Martin B, Michel S, Shroot B.

J Med Chem. 1995 Dec 22;38(26):4993-5006.

PMID:
8544175
42.

Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.

Dawson MI, Jong L, Hobbs PD, Cameron JF, Chao WR, Pfahl M, Lee MO, Shroot B, Pfahl M.

J Med Chem. 1995 Aug 18;38(17):3368-83.

PMID:
7650690
43.

p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.

Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA.

Oncogene. 1995 Aug 3;11(3):493-504.

PMID:
7630633
44.

Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding protein.

Sass JO, Hartmann J, Chahoud I, Shroot B, Nau H.

Toxicol Lett. 1995 Jan;75(1-3):159-68.

PMID:
7863522
45.

Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes.

Vecchini F, Mace K, Magdalou J, Mahe Y, Bernard BA, Shroot B.

Br J Dermatol. 1995 Jan;132(1):14-21.

PMID:
7756127
46.

Fatty acids and retinoids act synergistically on adipose cell differentiation.

Safonova I, Reichert U, Shroot B, Ailhaud G, Grimaldi P.

Biochem Biophys Res Commun. 1994 Oct 28;204(2):498-504.

PMID:
7980506
47.

Retinoids are positive effectors of adipose cell differentiation.

Safonova I, Darimont C, Amri EZ, Grimaldi P, Ailhaud G, Reichert U, Shroot B.

Mol Cell Endocrinol. 1994 Sep;104(2):201-11.

PMID:
7988747
48.

Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene.

Vecchini F, Lenoir-Viale MC, Cathelineau C, Magdalou J, Bernard BA, Shroot B.

Biochem Biophys Res Commun. 1994 Jun 30;201(3):1205-12.

PMID:
8024563
49.

[Synthetic retinoids. Selectivity for receptors and biologic activity].

Shroot B, Bernardon JM, Charpentier B, Reichert U.

J Pharm Belg. 1994 May-Jun;49(3):221-5. French. No abstract available.

PMID:
8057234
50.

Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in humans.

Buchan P, Eckhoff C, Caron D, Nau H, Shroot B, Schaefer H.

J Am Acad Dermatol. 1994 Mar;30(3):428-34.

PMID:
8113456

Supplemental Content

Loading ...
Support Center